FOSUN HEALTH Logo

Diabetic Retinopathy Treatment

catalogue

Diabetic Retinopathy Treatment

Diabetic Retinopathy Treatment

The treatment of diabetic retinopathy is layered, and the layers are ordered by what each can change. The first layer belongs to the diabetes rather than the eye: glucose, blood pressure and lipid control slow the vessel disease at every stage, and no eye treatment works as well as it should without them. The second layer treats swelling of the macula — injections of anti-VEGF medication into the eye, which reduce the swelling, and focal or grid laser, which seals specific leaking points when the centre itself is not involved. The third layer treats proliferative disease: panretinal scatter laser, which makes fragile new vessels shrink and disappear by treating the deprived retina that drove them to grow, protecting the eye from bleeding and traction. The fourth layer is surgery — vitrectomy — for blood that will not clear, membranes that pull on the retina, and the tractional detachments that proliferative disease can produce. What unites the layers is a principle stated at the outset: the aim of all of it is to protect and preserve the sight the patient still has. Macular swelling caught early often improves; tissue already lost to closure, bleed or scar does not return. That is why treatment is offered at stages the patient cannot feel, and why the schedule matters as much as any single procedure.

The foundation: glucose, blood pressure and lipids

Before any eye treatment is discussed, the ground it stands on is set by three numbers:

  • Glucose control, measured over years. HbA1c averaged over time is what the vessels respond to. Tight control does not reverse existing damage, but it slows progression measurably — and it is the precondition that every other treatment assumes.
  • Blood pressure. Raised pressure accelerates retinal damage independently of glucose and worsens the outlook of every stage. It is treated as part of the eye plan, not adjacent to it.
  • Lipids. The hard, fatty exudates that damage the macula travel with lipid levels, and their control reduces one of the ingredients of macular damage.

What the foundation is and is not. It is not a substitute for treatment — an eye with macular swelling or new vessels is treated, whatever the readings. But it is the reason some eyes never reach those stages, and the reason treated eyes hold their ground. Control is the treatment that runs through all the others.

Injections for macular swelling: what anti-VEGF treatment does

When the macula is swollen and the centre is involved, the usual first treatment is a medication injected into the eye:

  • What the drug does. The deprived retina produces a signal (VEGF) that makes vessels leak and drives abnormal growth. Anti-VEGF medication blocks the signal, and the swelling it causes falls.
  • What the injection involves. The eye is numbed with drops, the medication is placed into the vitreous with a fine needle in minutes, and the patient goes home the same day. The procedure is briefer than the preparation around it.
  • What the schedule looks like. Treatment begins with a course of injections and continues according to what the macular measurements do — the OCT number at each visit decides the next step rather than the calendar alone.

What results to expect, honestly. Swelling caught early often improves, and the treatments are judged on measured macular change and reading vision over months. Eyes in which the swelling has been present a long time, or the centre has been damaged, improve less. The schedule is demanding — and it is the price of holding the centre.

Laser for swelling: focal and grid treatment

Laser has treated macular edema for decades, and it retains a specific place beside the injections:

  • What it is used for. Focal laser seals discrete leaking points around the macula; grid laser treats wider areas of diffuse leakage — both are used where the swelling sits away from the very centre or alongside injection treatment.
  • What the session involves. Drops numb the eye, a lens is placed on its surface, and a session of precisely placed burns takes minutes. It is an outpatient treatment, and the vision is usually blurred for hours afterwards.
  • What it achieves. The aim is not to sharpen the vision directly but to stop the leaking — to stabilise the macula and reduce the fluid that erodes it over time.

How laser and injections are combined. In many eyes the two are sequenced rather than chosen: injections reduce the swelling, laser closes the leaks that persist, and the measurements decide the order. The plan is written around the macula’s behaviour, not around a preference for either tool.

Scatter laser for new vessels: panretinal photocoagulation

Where new vessels have grown — or are about to — the laser is turned to a different task altogether:

  • The logic is indirect and worth understanding. New vessels grow because large areas of peripheral retina are starved of oxygen. Treating those areas with scattered burns removes the demand, and the new vessels shrink and disappear — the treatment works on the cause rather than on the vessels themselves.
  • What the treatment involves. Sessions of scattered laser spots across the peripheral retina, performed as an outpatient over one or more visits, with drops and a lens as for focal treatment.
  • What it trades. Scatter laser protects the eye from bleeding and traction — the complications that destroy vision — at the cost of some peripheral and night vision. That trade is discussed before it is made, because it is the central decision of this stage.

Why it is offered before anything has bled. The stage at which scatter laser works best is the one at which the patient notices nothing. The treatment is prophylactic in effect: its success is measured in bleeds and detachments that never happen.

Vitrectomy: blood that will not clear, membranes and traction

Surgery enters the plan when the disease has produced problems no laser or injection can reach:

  • Blood that obscures the retina. A bleed that will not clear on its own is removed, which restores the view both for the patient and for treating the rest of the eye.
  • Membranes that pull. Scar tissue contracted over the retina tugs at it and distorts or detaches it; the operation removes what is pulling and settles the retina back — the same principles as repairing a retinal detachment, here driven by diabetes rather than by a tear.
  • What the operation involves. The vitreous gel is removed through small openings, the retina is freed and stabilised, and laser is applied from inside the eye during the same procedure; a gas or oil bubble may hold things in place afterwards.

What surgery can and cannot do. It can clear, release and reattach — mechanical tasks, usually achievable. It cannot restore function in retinal tissue that the disease has already taken. That is why the operation is discussed with the patient in terms of protecting and rescuing what remains, before rather than after.

What treatment actually involves: visits, injections and monitoring

Most of the treatment of this disease is not any single procedure; it is the schedule built around them:

  • Injections come in courses, not singles. An eye treated for macular swelling is seen repeatedly over months, with the OCT measurement deciding the pace. Patients plan around the series rather than around one appointment.
  • Monitoring continues whatever is done. Laser, injections and surgery all live inside the same framework of graded review — each eye keeps its interval, and the grades are compared visit by visit.
  • The other eye is treated as part of the plan. An eye that has needed treatment obliges closer watching of its partner, which shares the same vessels and much of the same course.

What the patient controls. The measurements and the procedures are ours; the glucose, pressure and lipid control, and the attendance that keeps the schedule intact, are the patient’s. In this disease that division is unusually even, and the outcome depends on both halves being kept.

Frequently Asked Questions

Are the injections into the eye painful?

The eye is numbed thoroughly with drops, and sometimes with a small anaesthetic pad placed over the closed eye before the injection. What most patients feel is pressure rather than pain — a brief push as the medication is placed — and the whole procedure takes minutes. Afterwards the eye may feel gritty and look mildly red for a day. Patients who return for a series of injections are usually reassuring about this: the anticipation is harder than the injection.

How long will I need injections for?

It depends on how the macula behaves, which is why the measurements decide rather than the calendar. Some eyes need a course over months and then settle with long intervals between visits; others need ongoing treatment at longer intervals to hold the swelling down. The honest framing is that the injections are a relationship rather than an event: the OCT number at each visit, not a fixed count, determines when the series pauses or resumes.

Does laser treatment damage the vision?

Focal and grid laser around the macula are designed to stop leaking without harming the centre, and they are placed precisely to that end. Scatter laser is different in that its trade is deliberate: treating the peripheral retina costs some peripheral and night vision, in exchange for protecting the eye from bleeding and detachment — the complications that take central vision away entirely. Both trades are explained before treatment, and neither is chosen casually.

Why treat the whole peripheral retina when the problem is the new vessels?

Because the new vessels are a symptom rather than the disease. They grow where the retina has been starved of oxygen by closed vessels, and destroying the new vessels alone would leave the demand that regrows them. Treating the starved periphery removes the signal driving the growth, and the vessels shrink — treating the cause. It is the least intuitive and most important piece of logic in this disease.

Get a treatment plan built around your stage, not a template

Send the stage or findings of your last retinal examination for each eye, any OCT or angiography reports, the injection, laser or surgery history of each eye if any, and your recent HbA1c and blood pressure readings. A written plan covering what treatment is indicated for each eye, in what order, how soon it should start, how long a stay it needs, what an itemised estimate looks like and how follow-up at home would work follows within about 48 hours of complete records arriving.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*